Pacira | PCRX - Ebit

Stock Price
20.86
Daily Change
-0.16 -0.76%
Monthly
-16.89%
Yearly
-23.00%
Q1 Forecast
19.91

Pacira reported $13.15M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Astellas Pharma JPY 104.41B 11.87B Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 5.11B 2.3B Dec/2025
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025
Zoetis USD 975M 40M Sep/2025